Latest inventory for ACB: $190M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Aurora Cannabis posts a inventory of $190M as of June 2026. That compares with $230M in the prior-year period — down 17.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Aurora Cannabis's inventory was $230M. The latest reading is $190M — a 17.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.
Inventory is one piece of Aurora Cannabis's financial statement story. At $190M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for ACB's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Aurora Cannabis's other metric pages and overview cover the third.
Judging Aurora Cannabis against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in inventory easier to interpret. Start with $190M here, then scan peer and history charts to see if the gap is persistent.